Literature DB >> 2862799

Overview: toward a dysregulation hypothesis of depression.

L J Siever, K L Davis.   

Abstract

The authors suggest that the activity of neurotransmitter systems in the affective disorders and related psychiatric syndromes may be better understood as a reflection of a relative failure in their regulation, rather than as simple increases or decreases in their activity. A model organized around the concept of "dysregulation" posits that persistent impairment in one or more neurotransmitter homeostatic regulatory mechanisms confers a trait vulnerability to unstable or erratic neurotransmitter output. Evidence from clinical and animal model studies for dysregulation of the noradrenergic system in depression is examined with respect to criteria generated by such a general model, and a specific configuration of noradrenergic dysregulation in some forms of depression is proposed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2862799     DOI: 10.1176/ajp.142.9.1017

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  54 in total

Review 1.  Future directions for brain, behavior, and the immune system.

Authors:  M Stein
Journal:  Bull N Y Acad Med       Date:  1992-07

Review 2.  Psychoneuroimmunology: potential relevance to chronic orofacial pain.

Authors:  S J Schleifer; J Marbach; S E Keller
Journal:  Anesth Prog       Date:  1990 Mar-Jun

3.  Longitudinal stability and developmental properties of salivary cortisol levels and circadian rhythms from childhood to adolescence.

Authors:  Elizabeth A Shirtcliff; Amber L Allison; Jeffrey M Armstrong; Marcia J Slattery; Ned H Kalin; Marilyn J Essex
Journal:  Dev Psychobiol       Date:  2011-09-27       Impact factor: 3.038

4.  Antepartum depression severity is increased during seasonally longer nights: relationship to melatonin and cortisol timing and quantity.

Authors:  Charles J Meliska; Luis F Martínez; Ana M López; Diane L Sorenson; Sara Nowakowski; Daniel F Kripke; Jeffrey Elliott; Barbara L Parry
Journal:  Chronobiol Int       Date:  2013-09-03       Impact factor: 2.877

5.  The effect of sympathetic antagonists on the antidepressant action of alprazolam.

Authors:  Ra Al-Tubuly; Sm Aburawi; Ea Alghzewi; Zm Gorash; S Errwami
Journal:  Libyan J Med       Date:  2008-06-01       Impact factor: 1.657

6.  Allostasis model facilitates understanding race differences in the diurnal cortisol rhythm.

Authors:  Martie L Skinner; Elizabeth A Shirtcliff; Kevin P Haggerty; Christopher L Coe; Richard F Catalano
Journal:  Dev Psychopathol       Date:  2011-11

7.  Pharmacologic specificity of antidepressive activity by monoaminergic neural transplants.

Authors:  D D Dougherty; C E Sortwell; J Sagen
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

8.  Chromaffin cell xenografts in the rat neocortex can produce antidepressive activity in the forced swimming test.

Authors:  C E Sortwell; G D Pappas; J Sagen
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

9.  Autonomic cardiovascular dysregulation as a potential mechanism underlying depression and coronary artery bypass grafting surgery outcomes.

Authors:  Tam K Dao; Nagy A Youssef; Raja R Gopaldas; Danny Chu; Faisal Bakaeen; Emily Wear; Deleene Menefee
Journal:  J Cardiothorac Surg       Date:  2010-05-13       Impact factor: 1.637

10.  Effects of centrally administered neuropeptide Y (NPY) and NPY13-36 on the brain monoaminergic systems of the rat.

Authors:  M Heilig; L Vècséi; C Wahlestedt; C Alling; E Widerlöv
Journal:  J Neural Transm Gen Sect       Date:  1990
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.